@techcrunch.com 2 years ago
How Cerebral and Alto Neuroscience embarked on an at-home clinical trial for depression
@xconomy.com 4 years ago
Disc Medicine Launches With $50M to Advance New Anemia Treatments
@techcrunch.com 4 years ago
Neurobehavioral health company Blackthorn pulls in $76 million from GV to treat mental disorders
@xconomy.com 5 years ago
Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More
@xconomy.com 5 years ago
Verana Health Lands $30M Financing Led By GV, Adds Miki Kapoor as CEO